EP PerMed Newsletter 20 | 15 July 2026

Dear subscribers,

in this summer edition of the EP PerMed Newsletter, we are pleased to share recent updates from across the personalised medicine community. This issue highlights new EP PerMed publications, including resources on personalised medicine strategies, policy and regulations, our new FAQ page, a report on returning biobank data to participants, a new example of advances and learnings in personalised medicine, the results of the EP PerMed Education Call 2025, and a new success story on personalising the fight against Long-COVID with non-invasive diagnostics.

We also look beyond EP PerMed and bring together selected news on European and international developments relevant to personalised medicine, from new funding opportunities and Horizon Europe updates to health data, rare diseases and precision medicine policy.

The EP PerMed Consortium

EP PerMed News

15 July 2026

New Resources on Personalised Medicine Strategies, Policy and Regulations

EP PerMed has published three new resources that bring together national, regional, and transnational policy documents and legal instruments relevant to the development and implementation of personalised medicine.

10 July 2026

New FAQ Explains Key Concepts in Personalised Medicine

EP PerMed has published a new Frequently Asked Questions page offering a clear introduction to personalised medicine, its practical applications, and the conditions needed for its responsible implementation across Europe.

08 July 2026

Report on Returning Biobank Data to Participants

EP PerMed has published a report on its session “Returning Biobank Data to Participants: Closing the Loop”, organised together with BBMRI-ERIC during Europe Biobank Week 2026 in Prague. The session took place on 20 May 2026 and brought together experts from biobanks, research infrastructures, patient organisations and clinical research to discuss how medically relevant research data and findings can be returned to participants in a responsible, transparent and participant-centred way.

26 May 2026

New APM: Idiographic Monitoring of Vertigo Triggers

EP PerMed presents a new example of "Advances and Learnings in Personalised Medicine" exploring how individual vertigo triggers can be identified in people with severe hearing loss and cochlear implants. By combining smartphone-based activity data with patient-reported information on symptoms, sleep, stress and hormonal factors, the project aims to better understand each person’s unique trigger profile. The approach highlights how personalised medicine can support daily life by helping patients anticipate vertigo crises rather than only reacting once they occur.

21 May 2026

EP PerMed Education Call 2025 - Announcement of Call Results

Six outstanding projects have been selected for funding under the EP PerMed Education Call 2025. Launched in June 2025, the Education Call supports the creation of educational content aimed at equipping healthcare professionals with the knowledge, skills, and competencies needed to integrate personalised medicine into their daily practice.

18 May 2026

New Success Story on Personalising the Fight Against Long-COVID with Non-Invasive Diagnostics

While many individuals recover from an acute COVID-19 infection, millions worldwide continue to suffer from debilitating symptoms months later. This condition, known as Long-COVID or Post-Acute Sequelae of SARS-CoV-2 (PASC), remains a significant challenge for modern medicine. The UriCov project has achieved a major scientific milestone by developing a novel diagnostic model based on urinary peptidomics. While most diagnostic efforts focus on blood or DNA, UriCov uses urine as a non-invasive and rich source of biological information.

Other PM-related News

06 July 2026

Draft Horizon Europe Health Work Programme Available

The European Commission has published a draft amendment to the Horizon Europe Work Programme 2026-2027, Part 4: Health, through the Comitology Register. The draft includes several potential 2027 call topics of interest to the personalised medicine community.

02 July 2026

ERDERA Clinical Trial Call 2026

The European Rare Diseases Research Alliance (ERDERA) has launched its Clinical Trial Call 2026 to support multinational, GCP-compliant early-phase interventional clinical trials in rare diseases.

01 July 2026

EIT Health Opens two Funding Opportunities for Healthcare Innovation

EIT Health has published two funding opportunities to support the development, commercialisation and uptake of innovative healthcare solutions in Europe. The calls are relevant for innovators working on new approaches in areas such as biotech, medtech, digital health, artificial intelligence, biomarkers and diagnostics.

18 June 2026

TEHDAS2 Guidelines to Support the Practical Implementation of the European Health Data Space

TEHDAS2 has published ten guidelines and technical specifications to support the practical implementation of the European Health Data Space (EHDS) across Member States. The documents address key aspects of the secondary use of health data, including fees and penalties, data access procedures, data protection, secure IT systems, citizens’ rights, and the responsibilities of health data access bodies and health data holders. Together, they provide practical guidance for organisations preparing for the implementation of the EHDS and its provisions on the reuse of health data.

16 June 2026

World Health Assembly Endorses Resolution on Precision Medicine

The Seventy-ninth World Health Assembly has endorsed a new resolution on precision medicine. The resolution underlines the importance of targeted, personalised and equitable care for strengthening health systems worldwide.

15 June 2026

ICPerMed Best Practice Example on Personalised Prevention

ICPerMed has awarded the ‘Best Practice Example in Personalised Medicine’ label to the Lerești Living Lab as a pioneering example of a personalised prevention initiative, tailoring cancer prevention to people’s lived realities, social relationships, local routines and access conditions in a rural community.

08 June 2026

New ICPerMed Best Practice Example on Building a Pharmacogenomics Ecosystem for Precision Medicine in Africa

ICPerMed has awarded the ‘Best Practice Example in Personalised Medicine’ label to the AIBST/iPROTECTA Model. The African Institute of Biomedical Science and Technology (AiBST) is a leading institution advancing pharmacogenomics (PGx) and precision medicine in Africa, with a strong focus on generating clinically actionable, African-relevant genomic data. As a founding and active member of the African Pharmacogenomics Network, AiBST contributes to continent-wide efforts to understand genetic determinants of drug response and to make training resources widely accessible.

See all news